Full List Of Stories
Director dealings: Dechra director lowers stake
Dechra Pharmaceuticals revealed on Friday that director Tony Griffin had sold 25,000 ordinary shares in the FTSE 250-listed veterinary drugmaker.
Broker tips: Dixons Carphone, WHSmith, BT
RBC Capital Markets downgraded Dixons Carphone on Friday after a recent strong run but upgraded its stance on shares of WHSmith.
US open: Stocks mostly higher as bank earnings continue to roll in
Wall Street futures were mixed open early on Friday amid more solid first-quarter report cards from some of the nation's largest lenders.
Morgan Stanley beat Q1 expectations on surge in investment banking revenues
Banking giant Morgan Stanley topped first-quarter earnings estimates on Friday thanks to some better-than-expected investment banking and trading results.
US pre-open: Futures mixed after Dow Jones closes over 34,000 for first time
Wall Street futures were pointing to a mixed open ahead of the bell on Friday after the Dow Jones topped 34,000 for the first time in history yesterday.
Immunodiagnostic Systems recovers 'strongly' in H2
Diagnostic testing kits producer Immunodiagnostic Systems said on Friday that trading had "recovered strongly" in the second half of the year, bouncing back from adverse impacts stemming from the Covid-19 pandemic seen in the first half.
Grafenia FY revenues slide amid Covid-19, looks to 'double down' on software arm
Grafenia said on Friday that it would "double down" on its software unit and look to add complementary companies to the group after seeing revenues decline amid the Covid-19 pandemic.
Accsys H2 sales and revenues grow following 'rapid recovery'
Building products company Accsys said on Friday that it had seen strong sales and revenue growth in the second-half following a "rapid recovery" after the initial impact of Covid-19 in the first quarter.
Mediclinic FY revenues slide on 'significant impact' of Covid-19 lockdowns
Healthcare services group Mediclinic said on Friday that it had delivered a "robust" operating performance in the year ended 31 March, with revenues declining slightly due to the "significant impact" of initial Covid-19-related lockdowns and restrictions across the globe.